American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
By D. Saslow, C. Boetes, W. Burke, S. Harms, Martin O. Leach, C. Lehman, E. Morris, E. Pisano, M. Schnall, S. Sener and 5 more. Ca, 2007
2,696 citations recorded by the source corpus.
New evidence on breast Magnetic Resonance Imaging (MRI) screening has become available since the American Cancer Society (ACS) last issued guidelines for the early detection of breast cancer in 2003. A guideline panel has reviewed this evidence and developed new recommendations for women at different defined levels of risk. Screening MRI is recommended for women with an approximately 20–25% or greater lifetime risk of breast cancer, including women with a strong family history of breast or ovarian cancer and women who were treated for Hodgkin disease. There are several risk subgroups for which the available data are insufficient to recommend for or against screening, including women with a personal history of breast cancer, carcinoma in situ, atypical hyperplasia, and extremely dense breasts on mammography. Diagnostic uses of MRI were not considered to be within the scope of this review.
Subfields: Cancer Research, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging
View Paper: https://www.semanticscholar.org/paper/8c9b7672dad6b746bd6c386fe636ceef297d886d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Pathology and Forensic Medicine
In Radiology, Nuclear Medicine and Imaging
Citations in the corpus
- Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. (2010, background): “In addition, the ACS has issued guidelines, also based predominately on existing evidence, for the use of magnetic resonance imaging of the breast to screen for breast cancer [2].”
- Breast cancer statistics, 2015: Convergence of incidence rates between black and white women (2016, background): “It is also important that patients at high risk of breast cancer are identified and offered appropriate screening and follow-up.(77) In addition, increased efforts are required to ensure that all segments of the population receive consistent follow-up of abnormal results, prompt diagnosis, and the d”
- Risk Factors and Preventions of Breast Cancer (2017, background): “Women with a family history of breast cancer have an approximately 20-25% or higher lifetime risk of breast cancer as demonstrated by MRI screening [94].”
- Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening (2018, background): “Annual MRI and mammography also are recommended for women who were treated for Hodgkin disease with radiation to the chest between ages 10 and 30 years and women with Li-Fraumeni, Cowden, and Bannayan-Riley-Ruvalcaba syndromes.(4) At the time these recommendations were issued, there was insufficient”
- American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline (2016, positive): “High risk is defined as a woman with a lifetime risk of a second primary breast cancer >20%, such as a woman with a BRCA1/BRCA2 mutation or a very strong family history of breast cancer.(21)”